Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making
Latest Information Update: 04 Dec 2023
At a glance
- Drugs BTRX 246040 (Primary)
- Indications Anxiety; Major depressive disorder
- Focus Therapeutic Use
- 28 Nov 2023 Status changed from recruiting to active, no longer recruiting.
- 03 Nov 2022 Status changed from not yet recruiting to recruiting.
- 31 Jan 2022 Planned initiation date changed from 15 Jan 2021 to 1 Oct 2022.